Related Experiment Video
Updated: Feb 14, 2026
04:30
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
26.4K
Therapeutic Options for In-Stent Restenosis
Charles Nicolais1, Vladimir Lakhter1, Hafeez Ul Hassan Virk2
1Division of Cardiovascular Diseases, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
Current Cardiology Reports
|February 14, 2018
Summary
In-stent restenosis (ISR) management has evolved. Repeat stenting with drug-eluting stents offers the best outcomes, while drug-coated balloons provide an effective alternative for in-stent restenosis treatment.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
Background:
- In-stent restenosis (ISR) is a complex complication following stent placement.
- Understanding ISR is crucial for effective patient management.
Purpose of the Study:
- To define in-stent restenosis (ISR).
- To summarize and evaluate treatment options for ISR developed over two decades.
Main Methods:
- Review of major treatment options for ISR.
- Analysis of recent network meta-analyses comparing various treatment modalities.
- Head-to-head comparison of treatment approaches for ISR.
Main Results:
- Second-generation drug-eluting stents for repeat stenting show the best angiographic and clinical outcomes.
- Drug-coated balloon therapy is an effective alternative when repeat stenting is not preferred.
- Bioresorbable vascular scaffolds represent new potential treatments for ISR.
Conclusions:
- Repeat stenting with second-generation drug-eluting stents is the preferred strategy for ISR.
- Drug-coated balloons offer a viable alternative for managing ISR.
- Ongoing research into novel therapies like bioresorbable vascular scaffolds continues to advance ISR treatment.
Keywords:
Balloon angioplastyBare metal stentDrug-eluting stentIn-stent restenosisNeo atherosclerosisRotational atherectomyMore Related Videos
Related Concept Videos
01:13Therapeutic Index
7.0K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
7.0K
01:30Therapeutic Communication
8.8K
Communication is a lifelong learning process. Through therapeutic communication, nurses can collect relevant assessment data, provide education and counseling, and interact during nursing interventions. Sending and receiving messages occur through verbal and nonverbal communication techniques and can happen separately or simultaneously.
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
8.8K
01:26Cholinergic Antagonists: Therapeutic Uses
1.5K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.5K
01:29Microorganisms in Medicine and Therapeutics
1.2K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.2K
01:30Adrenergic Agonists: Therapeutic Uses
2.0K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
2.0K
01:31Skeletal Muscle Relaxants: Therapeutic Uses
1.0K
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.0K